The surface of many Gram-negative bacteria contains lipidated protein molecules referred to as surface lipoproteins or SLPs. SLPs play critical roles in host immune evasion, nutrient acquisition and regulation of the bacterial stress response. The focus of this review is on the SLPs present in Neisseria, a genus of bacteria that colonise the mucosal surfaces of animals. Neisseria contains two pathogens of medical interest, namely Neisseria meningitidis and N. gonorrhoeae. Several SLPs have been identified in Neisseria and their study has elucidated key strategies used by these pathogens to survive inside the human body. Herein, we focus on the identification, structure and function of SLPs that have been identified in Neisseria. We also survey the translocation pathways used by these SLPs to reach the cell surface. Specifically, we elaborate on the strategies used by neisserial SLPs to translocate across the outer membrane with an emphasis on Slam, a novel outer membrane protein that has been implicated in SLP biogenesis. Taken together, the study of SLPs in Neisseria illustrates the widespread roles played by this family of proteins in Gram-negative bacteria.
INTRODUCTION
The cell envelope of Gram-negative bacteria is composed of two membranes, an inner cytoplasmic membrane and an outer membrane (OM), separated by a periplasmic space containing a thin layer of peptidoglycan (Silhavy, Kahne and Walker 2010) . Both bacterial cell membranes possess integral membrane proteins that allow the passage of ions and biomolecules across the membranes. These integral membrane proteins are assisted by a large number of peripherally attached soluble proteins referred to as lipoproteins (Kovacs-Simon, Titball and Michell 2011) . Lipoproteins contain an N-terminal cysteine residue that is post-translationally modified with an acyl lipid group, which serves as a membrane anchor. In most Gram-negatives, lipoproteins are predominantly found on the periplasmic face of the inner and the outer membranes. The cellular machinery responsible for the biogenesis of lipoproteins is conserved throughout Gram-negative bacteria (Okuda and Tokuda 2011) .
In recent years, there have also been a growing number of reports of lipoproteins present on the surface of Gram-negative bacteria (Konovalova and Silhavy 2015) . These lipoproteins, referred to as surface lipoproteins or SLPs, are involved in nutrient acquisition, immune evasion and cellular signalling. Most SLPs are translocated from the inner membrane to the inner leaflet of the OM via a conserved translocation pathway. However, the machinery diverges for translocation across the OM. The mechanism of OM translocation has been identified for a few SLPs and it is proposed that different families of SLPs may utilise different systems to move across the OM (Wilson and Bernstein 2016) .
One of the most well-studied families of SLPs is present in the genus Neisseria. Members of this genus can be found to reside on the mucosal surfaces of animals, including at least 10 species that can colonise humans (Weyand et al. 2016) . Neisseria contains two human pathogens: Neisseria meningitidis (Nme), one of the leading causative agents of sepsis and meningitis, and Neisseria gonorrhoeae (Ngo) that causes the sexually transmitted disease gonorrhea. Nme and Ngo are both obligate human pathogens exhibiting unique adaptations that allow them to survive inside their host (Virji 2009 ). The importance of these pathogens in relationship to human health promoted fundamental research in these organisms including pioneering work in the understanding of OM protein and lipopolysaccharide biogenesis that resulted in the identification of the Bam and Lpt complexes in Nme (Voulhoux et al. 2003; Bos et al. 2004) . Furthermore, Nme and Ngo are targets for the development of vaccines. Two decades of research has resulted in the development of two protein-based vaccines against Nme serogroup B ( Giuliani et al. 2006; Granoff 2010; Jiang et al. 2010) . Interestingly, both vaccines use SLPs as vaccine antigens demonstrating the importance of this class of proteins. This wealth of information makes Neisseria a great model system for understanding the roles of SLPs in Gram-negative bacteria.
In this review, we aim to summarise the work that has been conducted on neisserial SLPs. We will focus on their identification as well as their structural and functional characterisation. Furthermore, we will examine the translocation machinery required for SLP surface localisation in Neisseria with an emphasis on Slams, a novel class of OM proteins that are necessary for neisserial SLP surface display (Hooda et al. 2016 ). This review provides a framework for the research that has been done on this fascinating class of proteins and highlights the key roles they play in bacteria.
IDENTIFICATION OF SLPs IN Neisseria
Neisseria have compact genomes of 2-3 Mb that contain roughly 2500 genes. Based on DOLOP prediction software (Babu et al. 2006) , 69 out of 2002 open reading frames (ORFs) are predicted to encode lipoproteins in the Nme reference strain MC58. The ratio of lipoproteins to total ORFs in Neisseria (∼3.4%) is similar to other Gram-negative bacteria such as Escherichia coli (∼2%). However, if we apply the 'n+2' rule to predict Neisseria inner membrane-retained lipoproteins within this set of putative lipoproteins (Okuda and Tokuda 2011) , only one inner membrane lipoprotein (HtrA, NMB0532) would be predicted. This suggests that the rules that govern the retention may differ between E. coli and Neisseria species and requires additional work. Furthermore, we cannot currently predict if a given lipoprotein is present on the surface (SLP) or the periplasmic face of the OM. Hence, the identification of a SLP requires experimental work.
A number of experimental assays have been developed to identify these surface-exposed lipoproteins or SLPs. First, cell fractionation assays can be used to identify the presence of the lipoprotein in the inner and the outer membranes (Narita and Tokuda 2010) . Second, in vivo lipidation of a lipoprotein can be tested by quantifying the amount of radiolabelled lipoprotein in bacterial cells supplemented with 3 H-palmitic acid (Anderson, Sparling and Cornelissen 1994) . Third, dot blots or proteinase K shaving assays can be used to test the surface exposure of the lipoprotein and its sensitivity to protease activity respectively (Hooda et al. 2016 ). An alternative strategy has been to use flow cytometry or high-resolution fluorescence microscopy using fluorescently labelled antibodies against the lipoprotein for their detection on the cell surface (Lauber, Cornelis and Renzi 2016) . Finally, electron microscopy has been used to confirm the surface display of a handful of SLPs (Fletcher et al. 2004 ). All of these assays help in identifying a bona fide SLP and have been used in a number of bacterial species. However, these techniques are time consuming and not applicable at a genome scale. Most of the current knowledge on neisserial SLPs comes from either examination of iron acquisition systems or vaccine development against neisserial pathogens. As traditional capsulebased vaccines have been ineffective against Nme serogroup B, large efforts have been given to the development of a protein or an outer membrane vesicle (OMV)-based vaccine. This is illustrated by the extensive study conducted by Pizza et al. in which 350 candidate protein antigens were identified in Nme. These candidate proteins were used to immunise mice to identify the production of a bactericidal antibody response against the pathogen (Pizza et al. 2000) . Using this approach, four potential vaccine antigens were identified, two of which were later confirmed to be SLPs. This work led to the development of 4CMenB, a recent FDA and EMA-approved vaccine, and demonstrates the efficacy of SLPs as vaccine antigens (Vesikari et al. 2013) .
SLPs IN Neisseria
Based on our literature review, we have been able to identify eight different experimentally validated SLPs in Neisseria (Table 1 ). In the following sections, we will briefly summarise the major families of neisserial SLPs, the biochemical and structural information available on these SLPs, and their role in neisserial biology.
Transferrin binding protein B (TbpB)
TbpB was first identified from Nme strain B16B6 as a 71-kDa protein expressed under iron-limiting conditions (Schryvers and Morris 1988a) . The N-terminal sequence of TbpB showed homology to signal peptides of known lipoproteins (Legrain et al. 1993) . It was later shown that TbpB protein undergoes acylation, supported by the incorporation of 3 H-palmitic acid (Anderson, Sparling and Cornelissen 1994) . Treatment of intact cells with proteases resulted in a loss of TbpB exposed to the extracellular environment (Schryvers and Morris 1988a) . Schryvers and Morris further demonstrated that TbpB specifically binds to human transferrin, a human serum iron binding protein allowing Nme to overcome nutritional immunity (Hood and Skaar 2012) . The tbpB gene lies immediately upstream of the gene encoding a TonB-dependent OM receptor, TbpA (Legrain et al. 1993) . Nme B16B6 strain lacking either TbpA or TbpB was impaired in its ability to bind transferrin. In vitro assays revealed significant growth defects for TbpA or TbpB-deficient cells in the presence of transferrin as the sole iron source in comparison to WT cells. The tbpBA operon was also identified in Ngo, where TbpBA were shown to be co-transcribed under iron-limiting conditions (Ronpirin, Jerse and Cornelissen 2001) . Similar to Nme, an Ngo TbpB-deficient mutant bound 2-to 4-fold less labelled transferrin compared to WT cells and took up significantly less radioactive iron, suggesting that TbpB helps facilitate iron uptake (Anderson, Sparling and Cornelissen 1994) . Competitive solidphase binding assays illustrated that while TbpA binds apo and holo transferrin indiscriminately, TbpB preferentially binds ironloaded transferrin (Retzer et al. 1998) . The TbpBA iron acquisition system was found to be an essential virulence factor for Ngo et al. (2003) in a human male urethral colonisation model (Cornelissen et al. 1998) .
Structures of the apo form of Nme TbpB were solved independently by Calmettes et al. (2012) and Noinaj et al. (2012) . TbpB is a bilobed protein, and each lobe is comprised of a N-terminal β-handle and an eight-stranded C-terminal β-barrel (Fig. 1) . TbpB has a long, disordered anchoring peptide that may allow it to sequester transferrin at a greater distance from the bacterial cell surface. The holo structure shows the TbpB N-lobe in complex with the C-lobe of human transferrin loaded with Fe 3+ (Calmettes et al. 2012) . The binding interface is quite extensive, with a buried surface of ∼1450Å. Structural analysis suggests that TbpB stabilises the human transferrin thereby preventing the release of iron. This stabilisation may be important for TbpB's function in sequestering transferrin in an iron-loaded form near the cell surface until it is ready to be transferred to its partner, TbpA. The TbpA-TbpB-holo human transferrin complex was purified, and preliminary electron microscopy analysis suggests that these proteins form an oligomeric complex, further supporting the idea that TbpA and TbpB function together to acquire iron from transferrin (Yang et al. 2011; Noinaj et al. 2012) .
Lactoferrin binding protein B (LbpB)
Analogous to TbpBA system, Nme also contains a bipartite system for acquiring iron from lactoferrin (Brooks, Arutyunova and Lemieux 2014) . This system contains an integral OM transporter, LbpA, and an SLP, LbpB (Brooks, Arutyunova and Lemieux 2014) . LbpA was identified as an OM protein regulated by iron availability, and it specifically binds to human lactoferrin (Schryvers and Morris 1988b) . LbpB was later discovered by analysing the ORF immediately upstream of LbpA. LbpB shares 33% sequence identity with Nme TbpB and contains a putative N-terminal signal sequence followed by a signal peptidase II cleavage site, which is predictive of a lipoprotein (Pettersson et al. 1998 ). An LbpB single mutant exhibited a slight impairment in its ability to bind lactoferrin, but was able to grow in the presence of lactoferrin as the sole iron source. On the other hand, an LbpA single mutant was almost completely devoid of lactoferrin binding, and was unable to grow in the presence of lactoferrin (Pettersson et al. 1998) . Although its role in iron acquisition is not well understood, evidence points to a role of LbpB in pathogen defence. Lactoferrin is digested by pepsin at the N-terminus, releasing a short (49 amino acid) cationic antimicrobial peptide called lactoferricin that functions as part of the innate immune system (Hunter et al. 2005; Brooks, Arutyunova and Lemieux 2014) . Clusters of negatively charged residues present in the C-lobe of LbpB were hypothesised to bind the positively charged lactoferricin, and therefore neutralise the peptide (Morgenthau, Beddek and Schryvers 2014) . Nme expressing WT LbpB showed significant protection from the bactericidal activity of lactoferricin, while removal of the negatively charged residues increased susceptibility of the strain to lactoferricin (Morgenthau, Beddek and Schryvers 2014) . The neisserial autotransporter, NalP, was shown to cleave LbpB from the cell surface, releasing it into the extracellular environment (Roussel-Jazédé et al. 2010) . However, the cleaved lipoprotein was functional, could bind lactoferrin and protected bacteria from serum bactericidal antibodies.
Brooks, Arutyunova and Lemieux (2014) recently solved the structure of the N-lobe of LbpB from Nme by X-ray crystallography. Like TbpB, the N-terminal β-handle domain of LbpB contains predominantly β-strands, as well as an α-helix and a short 3 10 helix. LbpB also has a C-terminal eight-stranded β-barrel ( Fig. 1 ). Extensive loops from these two domains also form a cap structure. Since LbpB and TbpB are structurally very similar, it has been proposed that lactoferrin also binds to the loops of the LbpB N-lobe. The structure of LbpB was docked with the N-lobe of lactoferrin and shows that LbpB makes extensive contacts with the lactoferricin region of lactoferrin. This further supports the hypothesis that LbpB sequesters lactoferricin to protect the organism during infection.
Haemoglobin-haptoglobin utilisation A (HpuA)
HpuAB was initially discovered when Dyer et al. (1987) isolated a mutant of Nme called hga-1 (haemoglobin growth alteration), which was impaired in its ability to grow in the presence of AniA is predicted to be partially surface exposed with its NirK structural domain predicted to be in the periplasm suggesting that the lipid anchor may also be in the inner leaflet. NalP (blue-green) is an autotransporter protease for which the structure of membrane-bound β-barrel domain is available (PDB ID: 1UYN), while the protease domain is modelled based on structures of other serine proteases (PDB ID: 3AFQ).
haemoglobin as the sole iron source. A transposon cassette inserted into this gene, called hpu (haemoglobin-haptoglobin utilisation) resulted in a loss of production of an 85-kDa OM protein, called HpuB (Lewis and Dyer 1995) . Solid-phase binding assays and co-immunoprecipitation experiments illustrated that the HpuB mutant was unable to bind Hb or HbHp (Lewis and Dyer 1995) . A gene upstream of hpuB contained a putative lipobox motif and was annotated hpuA (Lewis et al. 1997) . 3 HPalmitic acid radiolabelling experiments and trypsin proteolysis assays illustrated that HpuA was lipidated and surface exposed, respectively (Rohde et al. 2002) . HpuA was shown to play a role in iron acquisition, as an HpuA deletion mutant was unable to grow in the presence of Hb or HbHp as the sole iron source (Lewis et al. 1999; Rohde et al. 2002) . Competitive binding assays revealed that HpuAB is not specific for human haemoglobin, suggesting that HpuAB are not determinants of host specificity. Haem was also unable to compete with haemoglobin for binding to the receptor complex, thus further supporting the notion that its ligand is Hb or HbHp (Rohde et al. 2002) . Rohde and Dyer (2004) developed a flow cytometry assay to assess equilibrium binding kinetics of HpuAB for both Hb and HbHp. A strain deficient in HpuA had a K d comparable to WT cells for Hb, but exhibited reduced binding to HbHp. Furthermore, WT cells had a much higher affinity for HbHp, compared to apo-Hp and Hb. These results conclusively point to a role of HpuA in facilitating HpuB's interactions with its ligand.
Structures of full-length and the C-terminal region of HpuA from Kingella denitrificans (Kd) and Neisseria gonorrhoeae respectively, were recently solved by X-ray crystallography (Wong et al. 2015) . Despite the low-sequence identity with SLPs such as TbpB, HpuA contains an N-terminal β-handle, and C-terminal eightstranded β-barrel (Fig. 1) . A co-crystal structure was obtained for Kd-HpuA in complex with tetrameric Hb, and revealed that several solvent exposed residues (Tyr 60, Phe 271, Tyr 272) in the apo structure form a hydrophobic interface with the Hb α and β chains. Deletion of the equivalent binding interface residues in Ngo-HpuA reduced the interaction between HpuA and Hb as assessed by pull down, suggesting that homologues of HpuA may recognise Hb through a common interface.
Factor H binding protein (fHbp/GNA1870/LP2086)
fHbp was independently discovered through a search for novel vaccine antigens against N. meningitidis. fHbp was shown to be lipidated by the incorporation of 3 H-palmitic acid, and surface exposed by flow cytometry and electron microscopy (Masignani et al. 2003; Fletcher et al. 2004 ). This SLP can be divided into subfamilies A and B, or into three variant groups (1, 2, 3) based on amino acid sequence diversity found in different Nme strains. Bactericidal assays demonstrated that antibodies raised against a particular variant group member can induce complementmediated killing of other strain members in the same group, but limited or no reactivity against other strain variants (Masignani et al. 2003) . fHbp was shown to bind specifically to human factor H, which functions to protect host cells by inhibiting the activation of the alternative complement pathway (Madico et al. 2006) . The ability to bind factor H provides Nme protection against complement-mediated killing (Madico et al. 2006; Schneider et al. 2006) . fHbp-deficient bacteria were also found to have more C3 present on the cell surface, suggesting that Nme utilises factor H to evade host innate immunity. Representative structures of fHbp from each of the three variant groups were solved by X-ray crystallography or NMR (Fig. 1) . The N-terminal domain is described as 'barrel-like', and is composed of six antiparallel β-strands facing two smaller ones and a short α helix (Cantini et al. 2009 ). The C-terminal domain is comprised of an eight-stranded antiparallel β-barrel and a short 3 10 helix. fHbp from the three variant groups all recognise factor H in the low nanomolar range (Johnson et al. 2012) . However, mutagenesis studies show that critical residues important for high-affinity binding vary in terms of both identity and location between the three variants (Johnson et al. 2012) . Schneider et al. (2009) solved the structure of variant 1 fHbp bound to a fragment of factor H containing complement control protein domains 6 and 7 (fH 67 ). The authors found that fHbp binds the same groove on factor H that binds to sulfated glycosaminoglycans, which are present on the surfaces of host cells, providing a structural basis for how Neisseria can co-opt human factor H for its own protection.
Neisseria heparin binding antigen (NHBA/GNA2132)
NHBA was identified in Nme through whole genome sequencing in an effort to identify novel vaccine candidates against serogroup B strains (Pizza et al. 2000) . NHBA contained a signal peptide with an LXXC lipobox, and was predicted to be an SLP. NHBA was detected on the bacteria cell surface by ELISA and flow cytometry assays using sera from mice immunised with purified protein (Pizza et al. 2000) . NHBA is not only found in pathogenic Neisseria, but is also present in commensal organisms like N. lactamica, N. flavescens and N. polysaccharea (Muzzi et al. 2013) .
Initial functional studies of NHBA demonstrated that it bound to heparin and enhanced survival in a human serum bactericidal assay (Serruto et al. 2010 ). An in vitro adhesion assay using purified recombinant protein showed that NHBA binds to heparan sulfate proteoglycans present on the surface of epithelial cells, and this binding is mediated through an arginine-rich region present on NHBA (Vacca et al. 2016) . NHBA deletion mutants are impaired in their ability to bind to epithelial cells, and sera against NHBA limits adhesion. NHBA has also been implicated in biofilm formation . Furthermore, a peptide fragment called C2 generated by NalP-mediated proteolysis of NHBA was found to increase the permeability of an endothelial cell monolayer (Casellato et al. 2014) . C2 led to the internalisation of VE-cadherin, a component of adherens junctions and it has been hypothesised to increase vascular permeability during meningococcal sepsis.
The structure of the C-terminal region of NHBA ( Fig. 1 ) was solved by NMR since the N-terminal region was predicted to be largely unstructured due to the presence of many small amino acids and low complexity sequences (Esposito et al. 2011) . NHBA contains an eight-stranded β-barrel, and is highly structurally similar to that of TbpB and fHbp despite their low-sequence identity. Sequence alignment of the barrel region demonstrated that many key residues important for transferrin and factor H binding are not present in NHBA (Esposito et al. 2011) .
Macrophage infectivity potentiator (Ng-MIP, Nm-MIP)
Ng-MIP was initially identified as a 30-kDa lipoprotein present in Ngo with homology to surface-exposed MIP proteins found in several intracellular pathogens such as Legionella pneumophila, Chlamydia trachomatis and Trypanosoma cruzi (Leuzzi et al. 2005) . These proteins exhibit peptidyl-prolyl cis/trans isomerase (PPIase) activity that can be inhibited by the macrolide antibiotic FK506 or rapamycin. Ng-MIP was shown to be an SLP using western blot analysis on Ngo OMVs, electron microscopy and 3 H-palmitic acid labelling experiments (Leuzzi et al. 2005) . AntiNg-MIP antibodies can be identified in sera from patients with urethritis and disseminated gonococcal infection (Starnino et al. 2010) . Deletion of Ng-MIP leads to decreased survival of Ngo in macrophages indicating a key role of MIP in intracellular survival.
A homologue of Ng-MIP referred to as Nm-MIP was also identified in Nme (Hung et al. 2011) . Nm-MIP was found to be upregulated in human sera and induced the production of protective antibodies against Nme. Both Nm-MIP and Ng-MIP are conserved within different Nme and Ngo strains (Humbert et al. 2015) . While no structure is available for neisserial MIPs, Humbert et al. used the structure of Legionella MIP proteins to model the structure of neisserial MIP. Based on the model, neisserial MIPs exist as homodimers with each monomer consisting of an N-terminal α-helix involved in dimerisation, a long central α-helix and a globular C-terminal domain containing the PPIase activity (Fig. 1) . Truncated Nm-MIP excluding the globular C-terminal domain was found to elicit bactericidal antibodies against different serogroups of Nme (Bielecka et al. 2015) .
Anaerobically induced protein A (AniA)
AniA was first identified as a lipoprotein that is expressed when Ngo is grown anaerobically (Hoehn and Clark 1992a,b AniA is composed of an N-terminal lipobox containing a flexible peptide region, a central copper (Cu)-containing nitrite reductase domain that has both type I and type II Cu centres, and a long glycosylated C-terminal extension (Boulanger and Murphy 2002; Ku et al. 2009) (Fig. 1) . First evidence for the surface exposure of AniA came from the observation that expression of AniA provided protection against killing by human sera (Cardinale and Clark 2000) . This was further validated by electron microscopy (ImmunoSEM) and trypsin digestion (Shewell et al. 2013) . Curiously, the trypsin digestion was unable to deplete the entire AniA protein suggesting that AniA may only be partially exposed on the cell surface. Such an orientation has previously been observed for RscF and Lpp in Escherichia coli (Konovalova and Silhavy 2015) . The most likely region that is surface exposed is the C-terminal glycosylated region that contains an immunodominant epitope (Shewell et al. 2013) .
Neisseria autotransporter lipoprotein (NalP/AspA)
Unlike the SLPs described above, NalP is a autotransporter SLP that has a distinct domain architecture composed of an Nterminal surface anchored protease domain and a C-terminal β-barrel domain embedded in the OM (Fig. 1) . NalP (AspA) was first identified as a 112-kDa autotransporter protein containing a serine protease catalytic triad found on several secreted subtilisin-like proteases (Turner, and AusI) from the surface of Nme (Van Ulsen et al. 2003) . NalP also cleaves neisserial SLPs NHBA and LbpB (Roussel-Jazédé et al. 2010; Serruto et al. 2010 ). The lipidation is important for retention of NalP on the surface, and loss of lipidation results in lower cleavage of its substrates (Roussel-Jazédé et al. 2013) .
Given its role in processing several important virulence factors, NalP was found to be important for the survival of Nme in human whole blood (Echenique-Rivera et al. 2011). Interestingly, NalP can also enhance human serum survival by directly cleaving the α-chain of the human complement factor C3b in a species-specific manner (Del Tordello et al. 2014) . Surface displayed NalP is antigenic and generates cross-reactive antibodies as confirmed by the presence of anti-NalP antibodies in patient sera (Turner, Wooldridge and Ala'Aldeen 2002) .
BIOGENESIS AND THE TRANSLOCATION PATHWAY OF SLPs
Lipoprotein precursors are synthesised in the cytoplasm with an N-terminal signal peptide. The signal peptide is about 20-30 amino acids in length and possesses a tripartite structure which consists of a basic (n region) at the N terminus followed by a hydrophobic region (h region) and a polar region (c region) at the C-terminus (von Heijne 1985 (von Heijne , 1989 Chatzi et al. 2013) . The last four residues at the C-terminus of the signal peptide is the conserved region referred to as the lipobox motif ([LVI] [ASTVI]
[GAS] C). The cysteine residue at the last position of the lipobox eventually becomes the first residue of the mature lipoprotein (Babu et al. 2006) .
Movement across the inner membrane: Sec/Tat translocons
Most of the unfolded preprolipoproteins are translocated across the inner membrane by the Sec translocon (Fig. 2) . The precursor lipoproteins interact with the SecA motor ATPase either directly or via chaperones (SecB) for post-translational export. Once the precursor is delivered to the Sec translocon complex (SecDEFGY), SecA provides the energy to push the preprolipoprotein through the SecYEG complex (Economou and Wickner 1994; Chatzi et al. 2013) . Alternatively, lipoproteins in some bacterial species can use the twin-arginine translocation (Tat) pathway instead of the Sec pathway. The Tat signal peptide is about 14 amino acids longer than the Sec-dependent signal peptide, and it contains a conserved sequence comprising of two arginine residues in its N terminus: SRRXFLK (Palmer and Berks 2012) . While the Sec pathway is ubiquitous and crucial for bacterial viability, the Tat genes are only present in half of the completely sequenced bacterial genomes. Nme and Ngo contain genes encoding both the Sec and the Tat components (Yen et al. 2002; Dilks et al. 2003) . However, based on sequence analysis of signal peptides in predicted lipoproteins in Nme, it seems most likely that neisserial lipoproteins listed above predominantly use the Sec pathway.
Biosynthetic enzymes: Lgt/SpII/Lnt
Once the preprolipoprotein is translocated across the inner membrane, it undergoes a series of post-translational modifications resulting in the attachment of a lipid group, anchoring the mature lipoprotein to the periplasmic leaflet of the inner membrane (Fig. 2) . The enzyme lipoprotein diacylglyceryl transferase (Lgt) covalently attaches a diacylglycerol to the thiol group of the cysteine residue forming a thioether linkage (Sankaran and Wu 1994) . This intermediate is termed a prolipoprotein. Signal peptidase II (SpII) then cleaves the signal peptide resulting in an apolipoprotein (Tokunaga, Tokunaga and Wu 1982) . Here, the cysteine residue becomes the first amino acid (+1). The last step is the acylation of the amino group of the terminal cysteine by apolipoprotein N-acyltransferase (Lnt) creating a mature triacylated lipoprotein (Gupta and Wu 1991) .
The lipoprotein biosynthetic enzymes appear to be essential for viability and mutations in these enzymes are lethal in most Gram-negative bacteria (Kovacs-Simon, Titball and Michell 2011). Studies have shown that deletion of biosynthetic enzymes results in the accumulation of Braun's lipoprotein in the inner membrane. As a consequence, the peptidoglycan becomes cross-linked to the inner membrane, causing cell lysis (Yakushi et al. 1997; Robichon, Vidal-Ingigliardi and Pugsley 2005) . However, in the genus Neisseria, it has been demonstrated that Lnt of Ngo is not essential for its viability (LoVullo et al. 2015) . Ngo can successfully deliver diacylated lipoproteins to the OM and does not possess a Braun's lipoprotein homologue. It is suggested that a different architecture of the localisation of lipoprotein (Lol) ABC transporter system may account for the loss of Lnt enzyme in Ngo.
Traversing across the periplasm: Lol system
Mature lipoproteins are predominantly exported from the inner membrane to the periplasmic leaflet of the OM by the Lol pathway (Okuda and Tokuda 2011) . The Lol pathway is comprised of five Lol proteins in Escherichia coli: Lol ABCDE. The LolCDE-ATP binding cassette (ABC) transporter resides in the inner membrane and releases lipoproteins that are destined to the OM in an ATP-dependent manner (Yakushi et al. 1998 (Yakushi et al. , 2000 . The periplasmic chaperone LolA (Matsuyama, Tajima and Tokuda 1995) then shuttles the lipoprotein from the inner membrane to the OM and delivers it to an OM receptor LolB (Matsuyama, Yokota and Tokuda 1997) (Fig. 2) .
LolA and LolB are the most well-characterised members of the Lol system. Both proteins share a common structural fold, consisting of an unclosed β-barrel, α-helical lid and a hydrophobic cavity (Takeda et al. 2003) . The N-terminal lipid moiety of a lipoprotein substrate binds to the hydrophobic cavity conferring protection against the hydrophilic environment of the periplasm (Tajima et al. 1998) . Compared to LolA, LolB binds lipoproteins with a higher affinity, which prevents back transfer and maintains unidirectional movement from the inner membrane to the OM (Taniguchi, Matsuyama and Tokuda 2005) .
The mechanism of inner membrane release by the ABC transporter, LolCDE, remains poorly understood. Photocrosslinking analyses performed by Mizutani et al. (2013) suggest that LolE binds to the lipoprotein and transfers it to LolA, which is situated near the inner membrane by using LolC as a scaffold. LolCDE also plays a role in deciding if the mature lipoproteins are directed to the OM or retained in the inner membrane. An Asp residue at position +2 was initially thought to be the sole amino acid that determines the retention motif (Yamaguchi, Yu and Inouye 1988; Seydel, Gounon and Pugsley 1999; Terada et al. 2001; Masuda, Matsuyama and Tokuda 2002) . Additional studies demonstrated that residues at positions +3 and +4 also influence lipoprotein localisation (Narita and Tokuda 2007) . However, additional studies have shown that these requirements may be specific to E. coli as other Gram-negative bacteria may possess different Lol sorting signals (Lewenza, Mhlanga and Pugsley 2008; Lauber, Cornelis and Renzi 2016) . This might also be true for Neisseria species, as only one lipoprotein (HtrA, NMB0532) seems to contain the retention motif.
LolA and LolCDE are well conserved in Gram-negative bacteria, while LolB has been found only in Beta-and Gammaproteobacteria (Okuda and Tokuda 2011; Liechti and Goldberg 2012; Szewczyk and Collet 2016) . Ngo, Nme and other Gramnegative bacteria including Francisella tularensis, Acinetobacter baumannii and Wolbachia sp. lack a lolE gene and are suggested to utilise a homodimer of LolC as the membrane component. Duplication of LolC has been hypothesised to be responsible for the ability of Ngo to transport diacylated lipoproteins to the OM (LoVullo et al. 2015) .
Role of periplasmic chaperones
SLPs enter the periplasm in an unfolded conformation through the Sec translocon. It has been hypothesised that premature folding of SLPs in the periplasm may prevent their movement across the OM (Szewczyk and Collet 2016) . Hence, it has been predicted that specific periplasmic chaperones may assist in the transport of lipoproteins to the OM. While the role of the periplasmic chaperones in the biogenesis of integral OM proteins is well understood (Ruiz, Kahne and Silhavy 2006) , their role in SLP biogenesis is poorly characterised. The requirement for a periplasmic 'holding' chaperone has been shown for Borrelia SLPs using a conditionally folding protein domain (Chen and Zückert 2011) . However, such studies are currently missing for SLPs in other Gram-negative bacteria. In Nme, the role of periplasmic chaperones SurA, Skp and DegQ (a homologue for E. coli DegP) in the surface display of fHbp was examined by Volokhina et al. Deletion of each of these three chaperones did not affect fHbp surface display suggesting that these chaperones either do not play a direct role in SLP biogenesis or SLPs, like OM proteins can utilise multiple chaperones to reach the OM (Volokhina et al. 2011) . Hence, further studies are required to identify chaperones that are involved in the transport of neisserial SLPs.
MOVEMENT OF SLPs ACROSS THE OM
The transport proteins and complexes involved in the transport of SLPs in Gram-negative bacteria is an active field of research (Wilson and Bernstein 2016) . One of the first families of SLPs for which the mechanism of surface translocation was discovered was the pullulanase (D'Enfert, Chapon and Pugsley 1987) . Surprisingly, pullulanase does not require the Lol system as it uses the type II secretion system to move across the periplasmic space and the OM. Apart from the type II secretion systems, type V secretion systems (Leyton, Rossiter and Henderson 2012) have also been shown to translocate SLPs across the OM. A number of recent review articles have covered the SLP translocation systems that are currently known in Gram-negative bacteria (Zückert 2014; Konovalova and Silhavy 2015; Szewczyk and Collet 2016; Wilson and Bernstein 2016) . In this section, we will focus on the OM translocation systems present in Neisseria.
Autotransporter mediated transport of NalP
The most well-understood translocation pathway in Neisseria is the type Va secretion system (autotransporter) used by the protease NalP (Turner, Wooldridge and Ala'Aldeen 2002) . A lot of work has been done towards understanding the mechanism of autotransporter function and it has been summarised previously (Leyton, Rossiter and Henderson 2012; Grijpstra et al. 2013; Bernstein 2015) . Briefly, after crossing the inner membrane through the Sec translocon, the autotransporters are delivered to the Bam complex by periplasmic chaperones SurA and Skp. The Bam complex assembles the C-terminal 12-stranded transporter domain in the OM. The insertion of the transporter domain leads to formation of a hairpin motif at the C-terminus of the passenger domain that allows the movement across the OM (Fig. 3A) . The lateral gate of the Bam complex is predicted to play a role in flipping the lipid anchor of NalP from the periplasmic leaflet to the surface after the transport of the protease domain.
Identification of Slams in Neisseria
As discussed in the section 'Biogenesis and the Translocation pathway of SLPs', the SLPs TbpB and fHbp are critical virulence factors for pathogenic Neisseria. These SLPs contain the SpII signal peptide, a lipobox motif, and a long and unstructured linker region followed by similar structural domains. The use of both SpII and the Lol system in the transport of TbpB was confirmed by globomycin treatment and with pulldowns using LolA mutants. TbpB expressed in Escherichia coli can be delivered to the OM, but is not displayed on the surface (Hooda et al. 2016) . Motivated by this observation, Hooda et al. performed a transposon mutagenesis screen to identify mutants unable to deliver TbpB to the surface of Nme. Hooda et al. identified an OM protein that is essential for the transport of not only TbpB but also LbpB and fHbp to the bacterial cell surface. Therefore, this OM protein was named Slam or surface lipoprotein assembly modulator (Hooda et al. 2016) .
Slam consists of an N-terminal domain containing tetratricopeptide repeats and a 14-stranded barrel domain (DUF560). Mutational analysis demonstrated that the membrane domain of Slam is essential for function (Hooda et al. 2016) . The addition of Slam allows E. coli to display neisserial SLPs on the surface suggesting that Slams play an important role in the transport of SLPs across the OM. Co-immunoprecipitation experiments showed that TbpB interacts with Slam while moving across the OM. Collectively, these results suggest that Slams are directly involved in the transport of SLPs across the OM (Hooda et al. 2016) . Two potential mechanisms for Slam-dependent cell surface localisation of SLPs include (i) the chaperone model where the Slam delivers proteins to another OM protein or complex such as the Bam complex, or (ii) the translocon model where the Slam membrane domain acts as a conduit for SLP translocation (Fig. 3B) . If model 2 is confirmed, Slams would be the first SLP-specific translocons in the OM resembling the two-partner secretion system in their function.
Rather than being a Neisseria-specific factor, Slams can be found throughout the phylum Proteobacteria. In Neisseria species, multiple Slams can be found in the genomes of both commensal and pathogenic Neisseria (Fig. 4) . Bioinformatics analysis identified a Slam paralogue, Slam2, that shares 26% sequence identity to Slam1 (Hooda et al. 2016) . The Slam2 gene lies adjacent to a gene encoding the known surface lipoprotein, HpuA. Interestingly, Hooda et al. (2016) demonstrated that Slam2 specifically delivers HpuA to the surface while Slam1 can translocate TbpB, LbpB and fHbp. This specificity of substrates is also exhibited by two-partner secretion systems and may control the delivery of SLPs in response to environmental cues, including changes in nutrient and immune effectors. Another interesting aspect of Slam-dependent SLPs is that despite their sequence diversity, they all share a similar structural fold, which includes an eight-stranded β-barrel domain that may be involved in Slamdependent transport.
Slams are found in all sequenced Neisseria species to date (Fig. 4) . In N. gonorrhoeae, three Slam homologues were found and in Neisseria lactamica four Slams were predicted. While a subset of Slams shared high-sequence similarity to either Slam1 or Slam2 of N. meningitidis, there were also a number of Slams that were different from Slam1 and Slam2, implying that they might transport different SLPs to the surface. Interestingly, many commensal neisserial species such as N. bacilliformis possess multiple Slams but have no known Slam-dependent SLPs. This suggests that many Slam-dependent SLPs have yet to be identified.
Translocation pathways for other neisserial SLPs
Slams and autotransporter systems can account for how five of the eight SLPs present in Neisseria get to the bacterial cell surface (Fig. 1) . Although there is currently no research available on the translocation of the remaining three SLPs, we can make predictions about their transport based on our review of the literature. For example, since NHBA and Slam-dependent SLPs are structurally similar, we can predict that the display of NHBA most likely requires a Slam. Given the specificity of Slam2 towards HpuA, and the observation that Slam1 translocates a broader set of substrates (TbpB, LbpB and fHbp), we predict that NHBA may be translocated by Slam1.
The dependence of AniA and Ng-MIP on Slam is harder to predict. These proteins are structurally different than the Slamdependent SLPs (TbpB, fHbp, HpuA and LbpB) identified to date. It would be interesting to test if their surface display is Slam dependent. However, the use of an alternate translocation apparatus such as the Bam complex is also possible. The Bam complex is composed of five membrane proteins that are crucial for the biogenesis of many OM proteins, including autotransporters (Hagan, Silhavy and Kahne 2011) . The Bam complex has also recently been directly linked to the transport of the SLP, RscF (Cho et al. 2014; Konovalova et al. 2014) . Mechanistic studies have shown that RcsF is loaded onto an OM porin, OmpA, during its assembly by the Bam complex. The lipoprotein and porin form a complex that remains together during the assembly process. Amongst neisserial SLPs, AniA may rely on a similar translocation pathway as RscF, given that it may be partially surface exposed. On the other hand, Ng-MIP has not been shown to bind to any OM protein. It is possible that Ng-MIP may directly interact with the Bam complex or another unidentified OM protein and translocate to the surface; however, this requires experimental validation.
Another potential SLP translocation apparatus is the Tam complex, which is a two-partner translocation system composed of an Omp85-family OM protein, TamA, and a large inner membrane chaperone protein, TamB . The Tam complex has been implicated in the transport of autotransporters and fimbriae (Stubenrauch et al. 2016) . Hooda et al. (2016) demonstrated that loss of the Tam proteins in E. coli does not have an impact on the Slam-mediated transport of TbpB. Despite this finding, the role of Tam proteins cannot be ruled out for other SLPs since TamA and TamB are both present in all neisserial species investigated so far.
CONCLUSIONS AND OUTLOOK
A large number of lipidated proteins, referred to as SLPs, are present on the surface of Gram-negative bacteria. SLPs play a wide variety of functions in Gram-negative bacteria including nutrient acquisition, immune evasion and cell adhesion. Recent review articles in the field have put forward the idea that SLPs are present in most bacterial species (Konovalova and Silhavy 2015; Wilson and Bernstein 2016) . In this minireview, we focused on the SLPs present in the genus Neisseria. Neisserial SLPs are one of the most well-characterised families of SLPs that are involved in a number of important cellular pathways and allow Neisseria species to survive inside their host. A phylogenetic tree of sequenced Neisseria genomes is shown using rplF sequences as described previously by Weyand et al. (2016) (the tree was generated using PhyML with 100 bootstraps). The number of Slam homologues found in each species is shown in parenthesis next to the species name. In each neisserial species, the presence of a homologue of a known neisserial SLPs is denoted +: SLP homologue found, -: SLP homologue not found. SLPs were identified using blastp with the Nme or Ngo SLP as query sequences. No Slams or SLPs could be identified in four neisserial species as their genomes are not currently available in the NCBI.
Eight bonafide SLPs have been found in Neisseria (Table 1) . Five of these SLPs display similar structural features such as the N-terminal β-handle domain and the C-terminal eight-stranded β-barrel domain. TbpB and LbpB possess two copies of this structural domain, while HpuA, fHbp and NHBA contain one (Fig. 1) . These lipoproteins are hypothesised to share a common structural ancestor, but have acquired novel functions (Esposito et al. 2011) . Another feature shared by TbpB, LbpB, HpuA and fHbp is the translocation machinery used by these SLPs. While all SLPs use the Sec translocon and the Lol machinery, these four SLPs require an OM protein called Slam to move across the OM (Hooda et al. 2016) . Hence, we refer to these SLPs as Slam-dependent SLPs.
Discovery of Slams in Neisseria has also raised crucial questions regarding the mechanism of how Slams modulate SLP translocation, and the mode of SLP recognition. Since Slams seem to be specific for SLPs with similar structural domains, we hypothesise that Slams recognise a conserved structural or sequence motif on their SLP substrates. Another key question in the field is the role of other OM proteins such as the Bam complex in Slam-mediated SLP transport. Further biochemical and structural studies are required to understand this mechanism at a molecular level.
In addition to Slams, autotransporters play a role in the translocation of SLPs to the cell surface in Neisseria. NalP is an autotransporter protease that processes proteins on the surface of Nme. NalP uses the autotransporter (Type Va) secretion pathway for its export as described previously (Leyton, Rossiter and Henderson 2012) . This pathway couples the secretion of the N-terminal passenger domain (the NalP protease domain) to the assembly of C-terminal transporter domain in the OM by the Bam complex. This mechanism is different from the Slamdependent system described in the previous section. Apart from the Slam-dependent and autotransporter-dependent SLPs, we still do not know the transport pathway for three neisserial SLPs: NHBA, Ng-MIP and AniA. Additional work is required to understand the mechanism by which these SLPs cross the OM.
While a number of SLPs have been identified in Neisseria to date, there may be more SLPs yet to be discovered. One such example is BamC, a member of the Bam complex that has been shown to be surface exposed in Escherichia coli . Given the sequence similarity between E. coli and Neisseria meningitidis BamC, it can be hypothesised that BamC may also be surface exposed in Neisseria. Further experiments are required to validate this prediction. Additionally, new neisserial species are being identified regularly and as their genomes are sequenced, bioinformatics approaches will be used to identify homologues of existing SLPs in these species. In this regard, the study of Slam and other translocation systems will assist in identifying additional SLPs whose functions are not known. Furthermore, improvements in proteomics-based approaches have provided an unbiased experimental approach towards identifying surface proteins of Gram-negative bacteria (Solis and Cordwell 2011) . Recently, Zielke et al. (2014) used mass spectrometry analysis on whole cells and OMVs to identify several surface-exposed proteins in N. gonorrhoeae, including putative SLPs.
We believe that the role of SLPs in bacterial cell biology has been underappreciated and further work needs to be done towards cataloguing and understanding the biogenesis machinery of SLPs. This will not only allow us to identify novel SLPs in other Gram-negative bacteria but also assist in the development of vaccines against other bacterial pathogens.
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